A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC

NCT00002046 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine

Sponsor

Glaxo Wellcome